T cell receptor Vβ5 and Vβ17 clonal diversity in cerebrospinal fluid and peripheral blood lymphocytes of multiple sclerosis patients

Multiple Sclerosis

Volumn 4, Issue 3, 1998, Pages 154-161

  Lozeron, P ^a   Chabas, D ^a   Duprey, B ^a   Lyon Caen, O ^a   Liblau, R ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Autoimmunity; Cerebrospinal fluid; Immunotherapy; Multiple sclerosis; T cell; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL POPULATION; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; GENE EXPRESSION; HLA TYPING; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PERIPHERAL LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0031680512     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400313     Document Type: Article

References (41)

1. Ebers GC, Sadovnick AD. (1997) Susceptibility: genetics in multiple sclerosis. In: Paty DW, Ebers GC (eds). Multiple sclerosis. FA Davis Company: Philadelphia pp. 29 - 47.
2. Sibley WA, Bamford CR, Laguna JF. (1985) Clinical viral infections and multiple sclerosis. Lancet 1: 1313 - 1315.
3. Wekerle H et al. (1994) Animal models. Ann Neurol 36: S47 - S53.
4. Traugott U, Reinhertz EL, Raine CS. (1983) Multiple sclerosis: distribution of T cells, T cell subsets and lapositive macrophages in lesions of different ages. J Neuroimmunol 4: 201 - 221.
5. Olerup O, Hillert J. (1991) HLA class II associated genetic susceptibility in multiple sclerosis: A critical evaluation. Tissue Antigens 38: 1 - 15.
6. Toyanaga B et al. (1985) Organisation and sequences of the diversity, joining, and constant region genes of the human T cell receptor β chain. Proc Natl Acad Sci USA 82: 8624 - 8628.
7. Pannetier C et al. (1993) The size of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germline segments. Proc Natl Acad Sci USA 90: 4319 - 4323.
8. Garboczi D et al. (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134 - 141.
9. Acha-Orbea H et al. (1988) Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54: 263 - 273.
10. Offner H et al. (1993) Where, when and how to detect biased expression of disease relevant Vβ genes in rats with experimental autoimmune encephalomyelitis. J Immunol 151: 506 - 517.
11. Gold DP et al (1991) Analysis of T cell receptor β chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementary determining region 3. J Exp Med 174: 1467 - 1476.
12. Howell MD et al. (1989) Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246: 668 - 670.
13. Vandenbark A, Hashim G, Offner H. (1989) Immunisation with a synthetic T cell receptor V region peptide protects against experimental autoimmune encephalomyelitis. Nature 341: 541 - 543.
14. Ben-Nun A et al. (1991) Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci USA 88: 2466 - 2470.
15. Kichert JR et al. (1995) Diversity of T cell receptor Vα, Vβ and CDR3 expression by myelin basic protein specific human T cell clones. Neurology 45: 1919 - 1922.
16. Chou YK et al. (1994) T cell receptor Vβ gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosis. J Neurosci Res 37: 169 - 181.
17. Vandevyver C et al. (1995) Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 25: 958 - 968.
18. Hafler A et al. (1996) TCR usage in human and experimental demyelinating disease. Immunol Today 17: 152 - 159.
19. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol 148: 1359 - 1366.
20. Kotzin L et al. (1991) Preferential T-cell receptor β chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 88: 9161 - 9165.
21. Wucherpfennig K et al. (1990) Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 248: 1016 - 1018.
22. Oksenberg J et al. (1993) Selection for T-cell receptor Vβ-Dβ-Jβ rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362: 68 - 70.
23. + T-cell population in newly diagnosed untreated HLA-DR2 multiple sclerosis patients. Proc Natl Acad Sci USA 93: 12461 - 12466.
24. Vandenbark A et al. (1996) Treatment of multiple sclerosis with T cell receptor peptides: results of a double blind pilot trial. Nature Medicine 2: 1109 - 1115.
25. Gold D et al. (1997) Results of a phase I clinical trial of a T cell receptor vaccine in patients with multiple sclerosis. II Comparative analysis of TCR utilisation in CSF T cell populations before and after vaccination with a TCR Vβ6 CDR2 peptide. J Neuroimmunol 76: 29 - 38.
26. Buenafe A et al. (1994) A TCR Vα CDR3 specific motif associated with Lewis rat autoimmune encephalomyelitis and basis protein-specific T cell clones. J Immunol 153: 386 - 394.
27. Lee S et al. (1991) Common T cell receptor Vβ usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol 29: 33 - 40.
28. Birnbaum G, Ness B. (1992) Quantitation of T cell receptor Vβ chain expression on lymphocytes from blood, brain and spinal fluid in patients with multiple sclerosis and other neurological diseases. Ann Neurol 32: 24 - 30.
29. Usuku K et al. (1996) Biased expression of T cell receptor genes characterizes activated T cells in multiple sclerosis cerebrospinal fluid. J Neurosci Res 45: 829 - 837.
30. Wilson DB et al. (1997) Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I Analysis of T cell receptor utilization in CSF cell populations, J Neuroimmunol 76: 15 - 28.
31. Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227 - 231.
32. Chomczynski P, Sacchi N. (1987) Single method of RNA isolation by acid guanidium isocyanate phenol chloroform extraction. Ann Biochem 162: 156 - 159.
33. Genevée C et al. (1992) An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 22: 1261 - 1269.
34. Pannetier C et al. (1995) T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 16: 176 - 181.
35. Hafler DA et al. (1985) In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 312: 1405 - 1411.
36. Noronha A, Richman DP, Arnason BGW (1985) Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations. Ann Neurol 18: 722 - 725.
37. Svenningsson A et al. (1993) Adhesion molecules expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol 34: 155 - 161.
38. Oksaranta O et al. (1995) Influx of nonactivated T lymphocytes into the cerebrospinal fluid during relapse of multiple sclerosis. Ann Neurol 38: 465 - 468.
39. Wucherpfennig K et al. (1992) T cell receptor Vα-Vβ receptoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med 175: 993 - 1002.
40. Rowen L, Koop BF, Hood L. (1996) The complete 685-kilobase DNA sequence of the human β T cell receptor locus. Science 272: 1755 - 1762.
41. Perron et al. (1997) Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA 94: 7583 - 7588.